![Craig Collard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Craig Collard
Amministratore Delegato presso
HERON THERAPEUTICS, INC.
Patrimonio netto: 1 M $ in data 31/05/2026
Profilo
Mr. Craig A. Collard is a Chief Executive Officer & Director at Heron Therapeutics, Inc., a Lead Independent Director at Terrascend Corp.
and a Director-Triangle Chapter at Cystic Fibrosis Foundation.
He is on the Board of Directors at Heron Therapeutics, Inc., Terrascend Corp., BioMarck Pharmaceuticals Ltd. and Hilltop Home Foundation.
Mr. Collard was previously employed as an Independent Director by Sierra Oncology, Inc., a Chairman by Opiant Pharmaceuticals, Inc., a President & Chief Executive Officer by Veloxis Pharmaceuticals A/S, a Chief Executive Officer & Director by Veloxis Pharmaceuticals, Inc., a Chairman & Chief Executive Officer by Cornerstone Therapeutics, Inc., a President, Chief Executive Officer & Director by Cornerstone Biopharma Holdings, Inc., a Chief Financial Officer by Cornerstone BioPharma, Inc., a President & Chief Executive Officer by Carolina Pharmaceuticals, Inc., a Vice President-Sales by Verum Pharmaceuticals, Inc., a Director-National Accounts by DJ Pharma, Inc., a President & Chief Executive Officer by Critical Therapeutics, Inc., and a Principal by Dura Pharmaceuticals, Inc. He received his undergraduate degree from Southern Polytechnic State University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
TERRASCEND CORP. 0,35% | 13/04/2026 | 1.076.538 ( 0,35% ) | 742 811 $ | 31/05/2026 |
| 30/04/2026 | 757.885 ( 0,4% ) | 659 360 $ | 31/05/2026 |
Posizioni attive di Craig Collard
| Società | Posizione | Inizio |
|---|---|---|
| TERRASCEND CORP. | Direttore/Membro del Consiglio | 06/12/2018 |
| HERON THERAPEUTICS, INC. | Amministratore Delegato | 03/04/2023 |
Cystic Fibrosis Foundation
 Cystic Fibrosis Foundation Miscellaneous Commercial ServicesCommercial Services Provides healthcare services and programs | Corporate Officer/Principal | - |
BioMarck Pharmaceuticals Ltd.
 BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new drugs for the treatment of pulmonary diseases and disorders | Direttore/Membro del Consiglio | - |
Hilltop Home Foundation
 Hilltop Home Foundation Hilltop Home Foundation is a private, nonprofit intermediate care facility with over 60 years of experience serving medically fragile children with severe to profound developmental disabilities. The private company is based in RALEIGH, NC. The facility supports up to 22 children, providing comprehensive, individualized, around-the-clock skilled nursing care by licensed professionals trained to manage complex health issues such as seizures, respiratory complications, and neuromuscular impairments. Hilltop Home Foundation offers a home-like environment emphasizing dignity, compassion, and safety, aiming to protect vulnerable children from abuse and neglect. The company's multidisciplinary care team includes executive and clinical directors, licensed nurses, dietitians, special education teachers, therapists, and support staff, ensuring continuity of care. The foundation provides a full range of personalized therapeutic services—including physical, occupational, speech, feeding, and respiratory therapies—designed to enhance mobility, communication, and overall quality of life. Educational services are delivered through a certified non-public school recognized by the North Carolina Department of Public Instruction, offering early intervention programs for children under five and partnering with Wake County Public Schools for older children. Certified special education teachers and assistants utilize assistive technology and language activities to foster communication, developmental progress, and confidence. Emergency medical care is accessible nearby, and the organization collaborates with community providers for additional psychological and nutritional support. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Craig Collard
| Società | Posizione | Fine |
|---|---|---|
| OPIANT PHARMACEUTICALS, INC. | Presidente | 02/03/2023 |
| SIERRA ONCOLOGY, INC. | Direttore/Membro del Consiglio | 01/07/2022 |
| VELOXIS PHARMACEUTICALS A/S | Amministratore Delegato | 01/12/2021 |
Veloxis Pharmaceuticals, Inc.
 Veloxis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for kidney transplant patients | Amministratore Delegato | 01/12/2021 |
| ░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Craig Collard
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
41
Relazioni di 1° grado
18
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 18 |
|---|---|
Heron Therapeutics, Inc.
 Heron Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and commercializes of polymer technologies | Health Technology |
Dura Pharmaceuticals, Inc.
 Dura Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets prescription pharmaceutical products | Health Technology |
Critical Therapeutics, Inc.
 Critical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes products for respiratory, inflammatory and critical care diseases | Health Technology |
Sierra Oncology, Inc.
 Sierra Oncology, Inc. BiotechnologyHealth Technology Develops novel therapeutic approaches for cancer and other diseases | Health Technology |
BioMarck Pharmaceuticals Ltd.
BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new drugs for the treatment of pulmonary diseases and disorders | Health Technology |
Cornerstone BioPharma, Inc.
 Cornerstone BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes biopharmaceutical products for respiratory disorders | Health Technology |
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for the prevention of organ rejection in kidney transplant patients | Health Technology |
Opiant Pharmaceuticals, Inc.
 Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops medicines for addictions and drug overdose | Health Technology |
Cornerstone Biopharma Holdings, Inc. | |
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation Miscellaneous Commercial ServicesCommercial Services Provides healthcare services and programs | Commercial Services |
Southern Polytechnic State University
 Southern Polytechnic State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DJ Pharma, Inc. | |
Cornerstone Therapeutics, Inc.
 Cornerstone Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for hospital and specialty care areas including respiratory, rare diseases & critical care | Health Technology |
Carolina Pharmaceuticals, Inc. | |
Verum Pharmaceuticals, Inc. | |
Hilltop Home Foundation
Hilltop Home Foundation Hilltop Home Foundation is a private, nonprofit intermediate care facility with over 60 years of experience serving medically fragile children with severe to profound developmental disabilities. The private company is based in RALEIGH, NC. The facility supports up to 22 children, providing comprehensive, individualized, around-the-clock skilled nursing care by licensed professionals trained to manage complex health issues such as seizures, respiratory complications, and neuromuscular impairments. Hilltop Home Foundation offers a home-like environment emphasizing dignity, compassion, and safety, aiming to protect vulnerable children from abuse and neglect. The company's multidisciplinary care team includes executive and clinical directors, licensed nurses, dietitians, special education teachers, therapists, and support staff, ensuring continuity of care. The foundation provides a full range of personalized therapeutic services—including physical, occupational, speech, feeding, and respiratory therapies—designed to enhance mobility, communication, and overall quality of life. Educational services are delivered through a certified non-public school recognized by the North Carolina Department of Public Instruction, offering early intervention programs for children under five and partnering with Wake County Public Schools for older children. Certified special education teachers and assistants utilize assistive technology and language activities to foster communication, developmental progress, and confidence. Emergency medical care is accessible nearby, and the organization collaborates with community providers for additional psychological and nutritional support. | |
Veloxis Pharmaceuticals, Inc.
Veloxis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for kidney transplant patients | Health Technology |
Terrascend Corp.
 Terrascend Corp. Agricultural Commodities/MillingProcess Industries Produces and sells medical cannabis products | Process Industries |
